Fulgent Genetics' GAAP net income for the 3 months of 2022 was $153.557 million, down 23.5% from $200.691 million in the previous year. Revenue decreased 10.9% to $320.268 million from $359.429 million a year earlier.
Fulgent Genetics' GAAP net income for the 3 months of 2022 was $153.557 million, down 23.5% from $200.691 million in the previous year. Revenue decreased 10.9% to $320.268 million from $359.429 million a year earlier. 
fulgentgenetics.gcs-web.com
English (US) 